Grufity logo
Grufity logo

Latest CAXTON CORP Stock Portfolio

$4,024Thousand | No. of Holdings #7

CAXTON CORP Performance

2026 Q1+3.86%
YTD+3.86%
2025+70.38%

About CAXTON CORP and 13F Hedge Fund Stock Holdings

On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, CAXTON CORP reported an equity portfolio of $4 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of CAXTON CORP are GLD, , . The fund has invested 81.5% of it's portfolio in SPDR GOLD TR and 8.7% of portfolio in BERKSHIRE HATHAWAY INC DEL. <br><br> The fund managers got completely rid off SPYRE THERAPEUTICS INC (AGLE), MIND MEDICINE MINDMED INC (MNMD) and COMPASS THERAPEUTICS INC (CMPX) stocks. CAXTON CORP opened new stock positions in ALX ONCOLOGY HLDGS INC (ALXO). The fund showed a lot of confidence in some stocks as they added substantially to SPDR GOLD TR (GLD) and BERKSHIRE HATHAWAY INC DEL.
CAXTON CORP Equity Portfolio Value
Last Reported on: 14 May, 2026
$4,024Thousand
  as of May 14, 2026

CAXTON CORP Annual Return Estimates Vs S&P 500

Our best estimate is that CAXTON CORP made a return of 3.86% in the last quarter. In trailing 12 months, it's portfolio return was 166.14%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
alx oncology hldgs inc41,996
New stocks bought by CAXTON CORP

Additions

Ticker% Inc.
spdr gold tr9.46
berkshire hathaway inc del2.39
Additions to existing portfolio by CAXTON CORP

Reductions

None of the existing positions were reduced by CAXTON CORP

Sold off

Ticker$ Sold
compass therapeutics inc-158,386
context therapeutics inc-27,053
mind medicine mindmed inc-210,058
sab biotherapeutics inc-39,371
spyre therapeutics inc-292,194
CAXTON CORP got rid off the above stocks

Sector Distribution

CAXTON CORP has about 96.2% of it's holdings in Others sector.

  • Others
  • Healthcare
Sector%
Others96.2
Healthcare3.8

Market Cap. Distribution

CAXTON CORP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MICRO-CAP
Category%
UNALLOCATED96.2
MICRO-CAP3.8

Stocks belong to which Index?

About 2.6% of the stocks held by CAXTON CORP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others97.4
RUSSELL 20002.6
Top 5 Winners (%)%
GLD
spdr gold tr
8.2 %
XFOR
x4 pharmaceuticals inc
3.3 %
Top 5 Winners ($)$
GLD
spdr gold tr
0.2 M
XFOR
x4 pharmaceuticals inc
0.0 M
Top 5 Losers (%)%
lexeo therapeutics inc
-42.2 %
IKT
inhibikase therapeutics inc
-18.1 %
kyverna therapeutics inc
-8.2 %
berkshire hathaway inc del
-4.6 %
Top 5 Losers ($)$
lexeo therapeutics inc
-0.1 M
berkshire hathaway inc del
0.0 M
kyverna therapeutics inc
0.0 M
IKT
inhibikase therapeutics inc
0.0 M

CAXTON CORP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of CAXTON CORP

CAXTON CORP has 7 stocks in it's portfolio. proved to be the most loss making stock for the portfolio. GLD was the most profitable stock for CAXTON CORP last quarter.

$4.02MTotal Value
12.00Positions
14 May, 2026Last Reported
Current holdings of Current Stock Holdings of CAXTON CORP, last reported on 14 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
GLD
Spdr Gold Tr

Spdr Gold Tr

GLD
CAXTON CORP's holding in Spdr Gold Tr over time
81.5%7,623
$3.28M
81.5%
increased 9.46 percentadded
Cl B New
Berkshire Hathaway Inc Del

Berkshire Hathaway Inc Del

CAXTON CORP's holding in Berkshire Hathaway Inc Del over time
8.66%727
$348.3K
8.66%
increased 2.39 percentadded
Com
Kyverna Therapeutics Inc

Kyverna Therapeutics Inc

CAXTON CORP's holding in Kyverna Therapeutics Inc over time
4.03%18,773
$162.0K
4.03%
unchanged 0 percentunchanged
Com
Lexeo Therapeutics Inc

Lexeo Therapeutics Inc

CAXTON CORP's holding in Lexeo Therapeutics Inc over time
1.99%13,943
$80.0K
1.99%
unchanged 0 percentunchanged